Bruker Stock News

BLB&B Advisors LLC lowered its holdings in Bruker Co. (NASDAQ:BRKR) by 18.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,846 shares of the medical research companys stock after selling 3,095 shares during the quarter. BLB&B Advisors LLCs holdings in Bruker []

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Companies covered in narcotics scanner market are Metrohm India Private Limited (India), Smiths Detection Group Ltd (The U.K.), LaserShield Systems Inc. (The U.S.), Aventura Technologies Inc. (The U.S.), Bruker Corporation (The U.S.), Chemring Group PLC (The U.K.), Leidos Holdings, Inc. (The U.S.), Safran SA (France), FLIR Systems Inc. (The U.S.), and more players profiled. Companies covered in narcotics scanner market are Metrohm India Private Limited (India), Smiths Detection Group Ltd (The U.K.), LaserShield Systems Inc. (The U.S.), Aventura Technologies Inc. (The U.S.), Bruker Corporation (The U.S.), Chemring Group PLC (The U.K.), Leidos Holdings, Inc. (The U.S.), Safran SA (France), FLIR Systems Inc. (The U.S.), and more players profiled.

Investors are optimistic about Bruker's (BRKR) better-than-expected results and strong segmental performance.

Global Molecular Spectroscopy Market Synopsis: Research analysts accomplish smart, resourceful and engaging surveys while creating Molecular Spectroscopy Market report that are sure to provide the better results. By leveraging the use of smart strategies and formats, the report helps businesses gain

Investors are optimistic about Bruker's (BRKR) better-than-expected results and strong segmental performance.

Scientific instruments manufacturer Bruker Corporation (BRKR) recently revealed that it has acquired molecular imaging instruments manufacturer MOLECUBES NV. The financial terms of the The post Bruker Acquires Molecular Imaging Instruments Producer MOLECUBES appeared first on Smarter Analyst .

Bruker (NASDAQ:BRKR) and Akoya Biosciences (NASDAQ:AKYA) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Valuation and Earnings This table compares Bruker and Akoya Biosciences revenue, earnings per share (EPS) []

(RTTNews) - Bruker Corporation (BRKR), a maker of scientific instruments for molecular and materials research, on Friday announced the acquisition of MOLECUBES NV, an innovator in benchtop preclinical nuclear molecular imaging or NMI systems. The financial terms of the deal are not known. Wulf Jung, President of the Bruker BioSpin Preclinical

GHENT, Belgium--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems. This acquisition strengthens Brukers position as a leading NMI solutions provider in preclinical and translational imaging research. The combination of Brukers preclinical imaging products and global footprint with the modular benchtop CUBES systems of MOLECUBES will provide a broader NMI offer

B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Bruker Co. (NASDAQ:BRKR) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 3,964 shares of the medical research company’s stock, valued at approximately $301,000. Several other institutional investors and hedge […]

Talking about these three developments, Bruker (BRKR) notes that because of complex sample preparation protocols, the widespread adoption of proteomics has been limited.

This Protein Crystallization market analysis is a potential resource for key players, stakeholders, and participants to know thoroughly about the industry growth factors. This market report further focuses on individual and industry growth developments relating to their contribution to the

Complete study of the global Process Analytical Technology (PAT) for Pharmaceutical market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a